<SEC-DOCUMENT>0001193125-17-223542.txt : 20170804
<SEC-HEADER>0001193125-17-223542.hdr.sgml : 20170804
<ACCEPTANCE-DATETIME>20170707060532
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001193125-17-223542
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20170707

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>CORRESP</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g400617g82e62.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Glen Y. Sato</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 650 843 5502</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">gsato@cooley.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">VIA EDGAR</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">July&nbsp;7, 2017 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities
and Exchange Commission </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">100
F Street, N.E. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Washington, DC 20549 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Re:</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Dynavax Technologies Corporation </B></TD></TR></TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Preliminary Proxy Statement on Schedule 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Filed June&nbsp;30, 2017 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>File <FONT STYLE="white-space:nowrap">No.&nbsp;001-34207</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of our client, Dynavax
Technologies Corporation (the &#147;<B><I>Company</I></B>&#148;), we hereby respond to comments received from staff (the &#147;<B><I>Staff</I></B>&#148;) of the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) in a
letter dated July&nbsp;6, 2017 (the &#147;<B><I>Comment Letter</I></B>&#148;), with respect to the Company&#146;s Preliminary Proxy Statement on Schedule 14A, filed on June&nbsp;30, 2017 (File
<FONT STYLE="white-space:nowrap">No.&nbsp;001-34207).</FONT> The numbering of the paragraphs below corresponds to the numbering of the comment letter, which, for the Staff&#146;s convenience, has been incorporated into this response letter. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>What happens if the increase in the authorized number of shares of common stock in Proposal 1 is not approved?, page 2</U> </I></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>1.</I></TD>
<TD ALIGN="left" VALIGN="top"><I>According to your Form <FONT STYLE="white-space:nowrap">8-K</FONT> filed on June&nbsp;2, 2017, you filed a Certificate of Amendment to the Sixth Amended and Restated Certificate of Incorporation with the Secretary of
State of the State of Delaware on June&nbsp;2, 2017 increasing the authorized number of shares of your common stock to 139,000,000. It does not appear you have accounted for this in your disclosure with respect to the effect of the vote. For
example, you state here that if Proposal 1 is not approved, your &#147;Sixth Amended and Restated Certificate of Incorporation, as amended, will remain as it is, and the authorized number of shares of [y]our common stock will remain unchanged.&#148;
You also state on page 9, &#147;If the amendment is adopted, it will become effective upon filing of a Certificate of Amendment...&#148; Please revise your disclosure here and throughout the preliminary proxy statement to clarify what will happen if
Proposal 1 is approved and what will happen if Proposal 1 is not approved. </I></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>Response:</B> If Proposal 1 is approved,
we will file the Certificate of Amendment included as Annex A in the preliminary proxy statement, which will supersede the Certificate of Amendment filed with the Secretary of the State of Delaware on June&nbsp;2, 2017 and confirm that our
authorized number of shares is 139,000,000&nbsp;million. If Proposal 1 is not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 3175 Hanover
Street Palo Alto, CA 94304-1130 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">t: (650) 843-5000 f: (650) 849-7400 cooley.com </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g400617g82e62.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Two </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">
approved, we will plan to promptly undertake steps to reduce the outstanding authorized common stock to 69,500,000 shares, the total prior to time the Certificate of Amendment was filed with the
Secretary of State of the State of Delaware on June&nbsp;2, 2017. We will revise references to the effect of approval and <FONT STYLE="white-space:nowrap">non-approval</FONT> in the preliminary proxy statement accordingly. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Page 2 References: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>&#147;What
happens if the increase in the authorized number of shares of common stock in Proposal 1 is approved? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the increase
in the authorized number of shares of our common stock is approved, we will file a Certificate of Amendment to our Sixth Amended and Restated Certificate of Incorporation, as amended, which will supersede the Certificate of Amendment filed with the
Secretary of the State of Delaware on June&nbsp;2, 2017 and confirm the increase in our authorized number of shares of common stock from 69,500,000 shares to 139,000,000 shares. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>What happens if the increase in the authorized number of shares of common stock in Proposal 1 is not approved? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the increase in the authorized number of shares of our common stock is not approved, we will plan to promptly undertake
steps to reduce the outstanding authorized common stock to 69,500,000 shares, the total prior to time the Certificate of Amendment was filed with the Secretary of State of Delaware on June&nbsp;2, 2017. Our ability to use our capital stock for
business and financial purposes may be limited and we may lose the flexibility to operate our business optimally, including a potential inability to fund our business and operations in accordance with our strategic plans.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Page 8 Reference: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;If our stockholders do not approve this Proposal 1, we will plan to promptly undertake steps to reduce the outstanding
authorized common stock to 69,500,000 shares, the total prior to time the Certificate of Amendment was filed with the Secretary of State of Delaware on June&nbsp;2, 2017. As a result, we may not be able to access the capital markets; complete
corporate collaborations or partnerships; attract, retain and motivate employees; or pursue other business opportunities integral to our growth and success.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Page 9 Reference: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;If this Proposal 1 is approved, we will file a Certificate of Amendment to our Sixth Amended and Restated Certificate of
Incorporation, as amended, which will supersede the Certificate of Amendment filed with the Secretary of the State of Delaware on June&nbsp;2, 2017 and confirm the increase our authorized number of shares of common stock
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 3175 Hanover
Street Palo Alto, CA 94304-1130 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">t: (650) 843-5000 f: (650) 849-7400 cooley.com </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g400617g82e62.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Three </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">
from 69,500,000 shares to 139,000,000 shares. If the amendment is adopted, it will become effective upon filing of a Certificate of Amendment of the Company&#146;s Charter with the Secretary of
State of the State of Delaware and the authorized shares would be available for issuance. No further stockholder authorization would be required prior to the issuance of such shares by the Company, except where stockholder approval is required under
Delaware corporate law or NASDAQ rules.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>Questions and Answers about these Proxy Materials and Voting</U> </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I><U>How many votes are needed to approve each proposal?, page 5</U> </I></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B><I>2.</I></B></TD>
<TD ALIGN="left" VALIGN="top"><B><I></I></B><I>Please expand your discussion of the votes needed to approve each proposal to state the effect of shareholders who do not provide instructions to their brokers/nominees.</I> </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>Response:</B> We will revise the discussion of the votes needed to approve each proposal as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><B>&#147;How many votes are needed to approve each proposal? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Proposal 1, to approve the amendment of the Company&#146;s Sixth Amended and Restated Certificate of Incorporation, as amended, to increase the
authorized number of shares of common stock from 69,500,000 to 139,000,000 shares, must receive &#147;For&#148; votes from the holders of a majority of the Company&#146;s outstanding shares entitled to vote. If you are a stockholder of record and
you fail to return your proxy card or to vote at all using the telephone or internet, it will have the same effect as an &#147;Against&#148; vote. If you are a stockholder of record and return a signed and dated proxy card without providing specific
voting instructions on Proposal 1, or do not specify your vote on Proposal 1 when voting using the telephone or internet, your shares will be voted &#147;For&#148; Proposal 1 in accordance with the recommendations of Dynavax&#146;s Board of
Directors.&nbsp;Abstentions will have the same effect as &#147;Against&#148; votes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">We believe that Proposal 1 is deemed to be a
&#147;routine&#148; matter. Therefore, if you are a beneficial owner of shares registered in the name of your broker or other nominee and you fail to provide instructions to your broker or nominee as to how to vote your shares on Proposal 1, your
broker or nominee will have the discretion to vote your shares on Proposal 1.&nbsp;Accordingly, if you fail to provide voting instructions to your broker or nominee, your broker or nominee can vote your shares on Proposal 1 in a manner that is
contrary to what you intend.&nbsp;For example, if you are against the approval of Proposal 1 but you do not provide any voting instructions to your broker, your broker can nonetheless vote your shares &#147;For&#148; Proposal 1. While we do not
expect any broker <FONT STYLE="white-space:nowrap">non-votes</FONT> on Proposal 1, if you do not provide voting instructions and your broker or nominee fails to vote your shares, this will have the same effect as an &#147;Against&#148; vote.&nbsp;If
you are a beneficial owner of shares registered in the name of your broker or other nominee, we strongly encourage you to provide voting instructions to the broker or nominee that holds your shares to ensure that your shares are voted in the manner
in which you want them to be voted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Proposal 2, to approve the continuation, adjournment or postponement of the Special Meeting
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 3175 Hanover
Street Palo Alto, CA 94304-1130 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">t: (650) 843-5000 f: (650) 849-7400 cooley.com </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g400617g82e62.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities and Exchange Commission </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Division of Corporation Finance </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page Four </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">for any purpose, including to solicit additional proxies if there are insufficient votes at
the time of the Special Meeting to approve Proposal 1, must receive &#147;For&#148; votes from the holders of a majority of the voting power represented at the Special Meeting, if a quorum of stockholders is achieved. If you are a stockholder of
record and you return your signed and dated proxy card without providing specific voting instructions on Proposal 2, or do not specify your vote on Proposal 2 when voting using the telephone or internet, your shares will be voted &#147;For&#148;
Proposal 2 in accordance with the recommendations of Dynavax&#146;s Board of Directors. If you are a stockholder of record and you fail to return your proxy card, or to vote at all using the telephone or internet, it will have no effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">We believe that Proposal 2 is deemed to be a &#147;routine&#148; matter. Therefore, if you are a beneficial owner of shares registered in the
name of your broker or other nominee and you fail to provide instructions to your broker or nominee as to how to vote your shares on Proposal 2, your broker or nominee will have the discretion to vote your shares on Proposal 2. If you return your
proxy and select &#147;Abstain,&#148; it will have the same effect as an &#147;Against&#148; vote.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Please contact the undersigned at (650) <FONT
STYLE="white-space:nowrap">843-5502</FONT> if you have any questions regarding the foregoing<I>. </I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>C<SMALL>OOLEY</SMALL> <SMALL>LLP</SMALL> </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Glen Y. Sato</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Glen Y. Sato</P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">cc:</TD>
<TD ALIGN="left" VALIGN="top">Steven N. Gersten, Vice President and General Counsel, Dynavax Technologies Corporation </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 3175 Hanover
Street Palo Alto, CA 94304-1130 </P> <P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">t: (650) 843-5000 f: (650) 849-7400 cooley.com </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g400617g82e62.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g400617g82e62.jpg
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MWIHJ[F!<<"(GV\\PB82+T@'\*K_+UB2?SK *CWF[E<-/$>=89'MDZ7#\-%_
M>$<<3Q[,HRZJB81H\5-F"O7A$ME!M:0EXV%C2<#MV;85-RR!>\D[C:Z5@."=
MEWP@4%Z4UV $$ZKS&3YA+-MAWN7U!.O @ZL(=FV&D%6<2HZ ""3RZQDQ"BXZ
M^<#=Q)J>5/.$J]BGE6[D*K?]U1J#PT\8]H8";6>13^(=,>&, ^V3Z5)'<00?
MPH]3UC*OC9W'J(RBV52[:Q?F\=Q&/2)82+K:;2$!P"B@;K]?'&%G)S:TMV$D
MGY;P-]/I6+"0FQ3N 4ILPIRAW.2CC[*31*Q3>G$>5W.)!G,L GQ.=X_0<O,G
MM=R=+N&HJV?NX<O2D)R6R#WEJ4!HN$-MH:39;2$)&K_KX?DV7[U"ROYDX\=?
M6$9+92:J6I8&C#\^D)2E "4BRD8 0\PV\FRXFNHZ1N,>ZFJ_$53AUI](:9;8
M39;33J=YB8E&Y@I*RH6,+-/J#%!2SB,(<R8RI54DM[!APU0Q(LL&U>M8P*M&
MX=A_39[6TC^U/^QZ_L+X<+2TM>-0IJIK\HD98RZ%6_B*.C4,.T#_Q  _$  "
M 0($ P4$!P0+ 0     ! @,$$0 2$R$%,4$4(C)181!"8G$S4G)S@9&S%2 C
M0P8D0%-48X*#DZ&CLO_:  @! 0 &/P+!BJ*P-.OBAIU:=U/DY3NHWHS XRM)
M4P?'-3G+_P"+.1^6%GII8YX7W62)@ZG\1U]/WZ)*%H@L\4K/J1"3=&4"U^7/
M$;'FR*3\RH/[Z<+H7,=1.F>HF0V>*%C9(XR/#(]FN>84"WBVCJN,YY))5#BB
M5GB6(-O:9T(=I;6V!7+RWZ911M3MTD@GF#K^$CNA_%3BII-;7C>NDJ(7ME;2
M>"GC"R#EG#1-RV.QVO8!Z^JCIPW@4YFD>W/)%&"[#U P(4KPCM8+KQ30(2>F
MI(@4?B1[&GJ9HX(4\4DC!5'D-^9/0<SC)VX\[9^S563\]'EZVPD]/*DT,@ND
MD;!D8>A&.&?<5'ZD>(?NH_\ Y&##+7*TBFS+!'+.%(YAGB0K?TO@]AJTF91=
MHN]',HY7,4@#9;];6P*.JK$@J6R6C=)=]39#GT\MB>M_._+V)%75:4\DBYT0
MK(S%;Y<UHT:PN"-_(X!\]^1'_1Y845'@_:?#19O#DR4NF#?W3M^?MJZUAF%-
M!)+E^LRJ<B7Z9FL/QQ5\4XO-))"DN0JK96FE(SZ0/\J!$*[+;Q "UL.*")J.
MJ"WB?6FDC9P.ZLJS._=)YE;$<]^1JN#5+,QI4UJ?.;M$B.(IH;GW0[QD#I=N
MG)Z#6:.AI9)44#<1P4QR2S*O(RRR<B>6HHY+C2%-*KVMV@5,VM>ULUBVG?K]
M';TQ^R'F,M'531PVY(XJ;"EJ ON2AF56_P!0\CCAGW%1^I'B&.!BDU=DI\X-
MF2'2S3%?B(LG^X>N(CQ&H6JKI$#3ZM+Q!DA9A<PQJD&3N\L^]R"0;8I.)?T8
MJV$B29I:?3JT2,K8@J:B-;Q2#,K1W/Y':CXY EI(8(IG'-C1U*K)OYZ3L&^3
M2'"232#7HAH5;,?[M;I.Q/1HMR?K*_EB6ND%Z*D83!6Y:,!R4<5CU=P'8?>>
MQ.-T:L3&BI6!/&@C^BJ1;?8=UCTRJ>5R(X.*2BDK(T"M-)M!46VU,XVC<\V#
M6'D>@+/Q2D>POEIY5J6/H%I\V^.,+31&)6>HHZ;4(S2-'3P3122#DEY9.5S8
M#%7PGB3=CS5!D22;N(DX589HIB?HC_"3=K#8WMM=YC64T\@6\5/!-'++,UNX
M (R<J$^^=ABOXQ*"$9'@5NDDTTJ3RE?/+D7_ ),5+5:L*6=IUU "?ZI52"6*
M9;>/*ZIF ^HPYC':#Q2ATK7N*F(GE>P0-F+_  6S>F(:FG1NR4\T$N8CPTM$
M0P9_JZL@V'^:/+'#/N*C]2/%%51 L*$AI@.D,T:*9/DKJE_M7Y#%/K4U!%6Q
MQ)'4Q3MINTJ+E:5,SC.CVS]V]LUCB&B:CIIGE.5GID,\5.;V43&-SWB=LJ!B
M.H&!2"->S"'LXA]S0R:>G;ZN3;'%N&0N5AJXM&Y_FT<C!XG'QZ>>,GXY!B-W
M6U176JI=N\J,/X$1^S'O;HTC>UI8UEH96W/92HA)\S"ZD#Y)DP&FK*R9!_+&
ME$&]&8*3;Y93ZX%/101T\(.;(@YL0 7=CN[V &9B3L/+&K,C05/^)ILJ2/M8
M:P*E9>FY&;:P. ]14U52BV.EW(4;T<H,Q7[)7YX2"GB2&&,62.-0B*/11C1K
M80]OHY5[LT)\XI.GRW!MN#B_;ZW3OX+09\OEJ9+7]<GX8T*&!8EVSOXI92/>
MED.[GGZ"^P&()*N6KC-.KHG9WA0$.03FU()-]NEL:+ /'DTRK@,&2V4AA:Q!
M&#+3RU%%F-S#'D>$?=JXNGRS$>0&%J )*NI3=):G*1$WUHHE4!6^(YB.A]@4
M=_A]'W;CPFCI&))]1-4-8>DH\O[#50\-"FKG310NXC$:R=V1[GWA'FMZD8G-
M4$[;4R=_(V<)#']$@;[1=C\QY>W_Q  @$ $!  (" P$! 0$        !$0 A
M,4%187$0((% _]H " $!  $_(<:9LJFB0F[]:P:;4!/=FT(=J#"$C&WW'2'3
MR$B"?W<YCPV\B(\ZVCM%!KZ_W:+?2YN)+!/*' 0GZ5HJT4>JKPVG"5\[$'-(
M;T241B*M#L,*#!^!P8T,)2I<4UE()"J[/>U<^<=82X[:35.2T%30+@VM[Q>-
MYB_1WQO.C!"R-M*(B<B([/VPC=?;6%!#+IVB(AFZ:6*+T_DK8WLS3>#6' %Q
MG")0J9(3-2WR $:5APX %@!41*4!7I!S4>$IP=  ;G&_[-@?<MO]!^L&UTIT
M(=[ZT=IC2MB:O3"8^(#BB/%3V+YA< X&%8]1V^7I@UH6&;B9#?E)=\.7PP"Z
MNEV*5)2ZA9 ,L .&^"NS@%NA! 8S)&$XHUO>T (!O:BI)##LZF@N86&/>Q80
M;^"&03).LUXQ$)U@+GNHFP<"2D9Y?EDBIT?7I =>$R;L)NLZ"C$*S6''0UAR
M6B#I.YU8;S50JY##AQ$0VW#HK6WP>$H-4TL&VA5I:JR"B$\V"KD["6=>!)^#
MD8KEVIC(.I05HC1G61['*-I>CK6VL%OJ,<'/:-=B'9,L;_J9,M.P?@/D.3YH
M3,$(QUX(3+BJNS75]88B4RX<B@3L_/XRCV\EHJT>9@CWL[JO8 [F]MHT?X@D
M2CI'B>)B1D:<^B_VC')(/"C6AYIOP#&:JI%P N60!6#/-3]4 !Z -( )K$NY
M2R7:UATO&\!'\K"@55?*J[<F^WR,Y*7B5Z34P"R;X+_0X"E"KB-#LI!2@)K#
M--#@\6(3*Q;S(X-/P2B1KK".+56>='K>!X(3%[%6*<"&E*K8?G> HJI)[:G)
MF\:-!P?\#Y8_2E.&G=G63S71"TB&V,YF_L#_V@ , P$  A #$   $ Z0  &
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MO5/)LD_("?RRG0/RB->Z"OF(?' 4],,GI06?$??!V:$\L%5JH!56!G''+"\
MI@A$CRF!!#@'T@%^4,/A7O@%PP  >@YHP:,/YV'LR/8\!Z=U+GC1??Z<G,>W
M:'>Q_P##H#BZT)0846^EU.;HPT((DD333?7$QYW)/P2_"H= <&DZ01>0 $Z6
KITG->IS##HTU>OTL.X/'->I_H%V8E6 X5\E3W'KBX RJH:E^56>3Q^?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
